Pirates and property: the moralities of branded and generic medicines by Keeyaa, Chaurey
!
!
Pirates and Property: The Moralities of Branded and 
Generic Medicines 
!
SO496 
19681 
!
!
!
!
!
!
Word Count: 9, 947 
!
!
!1
Table of Contents  
Acknowledgements          4 
!
Introduction           6 
!
A Note on Fieldwork          10 
!
Theoretical Framework and Context                13 
Of Conspiracies and Controversies: HIV/AIDS in South Africa     13 
A Discerning Disease          15 
Original Sin           19 
An Eerie Coincidence          23 
Matter out of Place          25 
!
Discussion and Analysis         28 
Piracy as Pretext           28 
Behaviours of Accumulation and Extraction        32 
Minds and Bodies for Extraction         35 
Piracy and Disorder          39 
!
!2
Conclusion           41 
!
Appendix           42 
!
Bibliography          43 
  
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!3
!
!
    
!
!
Acknowledgements 
!
!
I have so much gratitude to my friends who saved me; to my informants who gave me their 
time and words; my mentors at LSE who always had time for me; and my own body’s 
sometimes illness: my first inspiration.  
!
!
!
!
!
!
!
!
!
!
!4
!
!
!
!
!
!
!
!
The bloodstained body of the drug is so dangerous and frightening that we 
want to push it away altogether, but it hides in plain sight in the side effects. 
Behind the clean, molecular body of the pill is the injured flesh and blood of 
bodies that haunt both consumers and producers and will not haunt them 
quietly.  
Martin 2006, 284 
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Introduction 
!
The ‘drug’ has a multitude of meanings and functions: it could serve as a vehicle of 
biomedicine, inhabiting particular trends in medical thought; it could act as therapeutic relief; 
sometimes, a life companion, a sense of certainty; at other times, an annoyance. A ‘drug’ 
could be a political weapon; a symbol of various kinds of power; an expression of moral 
ideology; an object of mysterious workings and unexplained expense. In this dissertation, I 
am most concerned with the moral body of the antiretroviral (ARV) drug, and the moral 
differentiation between the bodies of branded and generic drugs. Biochemically speaking, 
branded and generic medicines are equivalent. Yet the latter is sold for a fraction of the 
former’s price. Wrapped in a web of intellectual property rights, branded drugs are out of 
reach to most of the world’s population. I ask: what moralities do branded and generic 
antiretroviral drugs inhabit and express? I locate this question within the HIV/AIDS crisis in 
South Africa. By conceptualising “medications as vehicles of ideology” (Nichter and 
Vuckovic 1994, 1509), I argue that branded ARVs come through and with the moral world of 
the pharmaceutical corporations (Big Pharma) that engineer, hoard, withhold, and sell them. 
This moral world facilitates insatiable accumulation and ever-expansion, and in context to 
this, generic ARVs then present themselves not simply as enemies to branded ARVs but as 
disorder.  
!
What makes South Africa special? Historians of South Africa continue to argue over whether 
the country is exceptional or an exemplar. The exceptionality thesis holds that the South 
Africa’s history is unique, while those that argue the exemplarity thesis say that the country is 
not special but a heightened colonial and postcolonial context (Fassin 2007, xx). I take an 
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approach to the South African situation that accounts for both. The South African local is 
both distinct from and a part of the global, and the history of South Africa that I deal with 
here is both informed by global colonialism and imperialism as well as a unique 
manifestation of those forces. By using the South African context as the anchor for my 
argument, I place an abstract argument into a desperately high-stakes environment.  
!
In statistical terms, the scale of the pandemic is breathtaking. First reported in South Africa in 
1983 (Karim 2005, 33), the emerging HIV/AIDS epidemic mainly affected white homosexual 
men, blood transfusion recipients, and haemophiliacs (Karim 2005; Rohleder et al. 2009). Yet 
in 1990, with the rate of infections doubling every 8.4 months, the most affected population 
quickly grew to be the African heterosexual population (Mbali 2013, 28). Strikingly, in the 
period from 1997-2006, the annual number of deaths rose by 93 percent, and among those 
aged twenty-five to forty-nine years, the rise was 173 percent. By 2010, almost six million 
people were living with HIV (Decoteau 2013, 6) and South Africa currently has the largest 
HIV epidemic in the world, with 19% of the global number of people living with HIV. To 
match, the country also has the largest treatment programme in the world, with 20% of the 
global number of people living on ARVs. Indeed, the government of South Africa has been 
instrumental in creating one of the world’s largest domestically funded programmes through 
funding 80% of the AIDS response (UNAIDS, n.d.). However, it is important to note that this 
has come neither quickly nor easily. 
!
These statistics both reflect and refract a sweeping history of racial capitalism, segregation, 
apartheid, and neoliberal power. I will argue that the moral world of Big Pharma, and its 
enactment into South Africa with the branded ARV drug, fits snugly into the moral worlds of 
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racial capitalism in South Africa, as well as colonialism and imperialism more globally. There 
are many apartheids revealed in this dissertation: the ‘medical apartheid’ (Mbali 2013) of Big 
Pharma’s withholding of access to life-saving medicines in South Africa, Africa, and the rest 
of the Third World; the HIV/AIDS crisis, dubbed by Archbishop Desmond Tutu, as ‘the new 
apartheid’ referring to both its scale and the necessity of urgent action; and the ‘global 
apartheid’ of neoliberalism and the globalisation of U.S. imperial power.  
!
This dissertation is structured as follows. In A Note on Fieldwork, I briefly describe my 
fieldwork, and make a case for decolonial fieldwork ethics. In the chapter Theoretical 
Framework and Context, I lay out the foundations of my argument. I explore the 
controversies and conspiracies of the South African HIV/AIDS crisis; the fundamental logics 
of racial capitalism as accumulation and expansion, and its connection to epidemiology and 
health care; neoliberalism’s ‘accumulation by dispossession’ (Harvey 2003); and Mary 
Douglas’s conceptualisation of dirt as ‘matter out of place’ (1966). In the Discussion and 
Analysis chapter, I argue that Big Pharma’s discursive construction of generics producers as 
‘pirates’, and the history of the intellectual property regime and the Agreement on Trade-
Related Aspects of Intellectual Property Rights (TRIPS) are the following through of their 
moral imperative. I will also show that from the perspective of Big Pharma’s morally 
commendable actions of accumulation and expansion, the existence and production of 
generic ARVS, and generics more broadly, are disorder. Thus, the offensive against generics 
by Big Pharma, especially in contexts of urgent need like South Africa, becomes more 
understandable.  
!
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The struggle for access to medicines is a desperately important human rights issue. Rather 
than ‘how do we get access to medicines?’, I ask the question ‘why do we not yet have access 
to medicines?’ in an attempt to fill in a gap in understanding capital’s moral obligation to 
itself and the fundamental human right of access to essential medicine.  
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A Note on Fieldwork 
!
I was given the opportunity to go to South Africa for my fieldwork through grants from the 
Firoz Lalji Centre for Africa and the Human Rights department. Travelling through Durban, 
Cape Town and Johannesburg I was able to interview seven informants across the fields of 
public sector health practitioners, academia, public health policy researchers, and intellectual 
property rights activism. I made contact with these informants through emailing their public 
email addresses, as well as visiting HIV/AIDS centres in Durban and the Médecins Sans 
Frontières (Doctors without Borders) Southern Africa offices in Johannesburg. The purpose 
of my interviews has been not to provide data upon which I will base my argument, but rather 
to enhance my argument. The short fieldwork time does not allow for true ethnographic 
fieldwork, and so the answers I would get in this time would be nothing more than vague. 
Knowing this, I aimed only to get different perspectives on the morality of Big Pharma, and 
their work in South Africa and Africa. As my interviews were not structured, the 
conversations became about these issues and so much more. My informants’ words will be 
incorporated into my analysis chapters to add depth to my argument .  1
!
 Apart from the very normal ethnographic refusal that forms part of one’s fieldwork, my 
greatest challenge was the ethics review process. The ethics review is an important aspect of 
all fieldwork. In my first ethics review, I had made the case for not using written consent and 
relying exclusively on verbal consent that would be recorded or witnessed. My case for 
verbal consent was that written consent, particularly in a context where people can be 
suspicious of documents and signatures, would ‘contractualise’ my interactions with my 
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 I use the singular ‘they’ pronoun to anonymise my informants as much as I can.1
informant. Especially because I wanted to take an ethnographic-like approach of free-form 
conversation and relationship-building through the interview, anything ‘contractualising’ 
would be counter-intuitive to informants opening up about their experiences with the HIV/
AIDS crisis, criticisms of the South African government, and the effects of apartheid. Here I 
want to make a distinction between written consent and immediate written consent. Written 
consent after the establishment of a relationship and trust is not the issue at hand. Due to the 
necessary time constraints of an MSc dissertation, fieldwork is very short, requiring what I 
call immediate written consent, or written consent without the establishment of trust. After 
my first ethics review was rejected, I supplied a script for verbal consent that I would say to 
each informant depending on their occupation. This too was rejected, with the ethics review 
committee unconvinced that health practitioners and activists in South Africa would be 
uncomfortable with strange documents presented to them by a stranger. After yet more back 
and forth with the ethics review committee, including the writing of a formal statement where 
I argued my case using decolonial ethics scholarship, I was finally given the decision that I 
should take it on a case by case basis.  
!
The point of relaying this in the methodology section of my dissertation is to not just report 
the difficulties in my fieldwork but to make a case once more for decolonial ethics in 
fieldwork. My argument is very consciously located within the MSc dissertation process, and 
I hold that the LSE ethics review committee does not fully take into account the complexities 
of research in non-Western contexts. Unfortunately, I do not have the space here to discuss 
the full scope of literature that makes the case for decolonial fieldwork ethics. Nevertheless I 
want to provide some insight into the gaps in Western ethical standards, and actually 
conducting fieldwork in a non-Western country.  
!11
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Molobela (2017), a South African researcher working in South Africa writes about the very 
real possibilities of coming across participants who may not not want to remain anonymous, 
who require compensation for the participation, or most notably for us, are suspicious of 
signing formal documents and favour written consent (Molobela 2017, 67). The webs of 
bureaucracy that are normal in Western countries are not necessarily seen the same way in 
non-Western, particularly post-colonial countries. Western universities cannot treat ethics as 
“one-size fits all” (Adu-Gyamfi 2014, 50). In my own fieldwork, I found the suspicion that I 
had expected when I presented informants with the option of written consent versus verbal 
consent, and four out of seven informants chose verbal rather than written consent. Adu-
Gyamfi (2014) advocates for a process described by Crigger, Holcomb and Weiss as ‘ethical 
multiculturalism’, or the understanding that in the many challenges of cross-cultural research, 
researchers working in non-Western countries have to not only adapt ethics to the local but be 
culturally literate to understand what that would entail (Adu-Gyamfi 2014, 50). I encourage 
both LSE departments, students travelling for fieldwork, and the ethics review committee to 
take seriously that the Euro-American centred ‘standards’ of research ethics do not fit neatly 
into non-Western contexts. In these situations, it is the responsibility of everyone involved to 
adapt and shift focus with the goal of decolonising ethics frameworks, even if only in a very 
simple and obvious way such as verbal rather than written consent.  
!
!
!
!
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Theoretical Framework and Context 
!
I draw largely from Marxist-influenced writing for my theoretical framework as well as Mary 
Douglas’s classical anthropological work Purity and Danger (1966). In the first section, 
through the narrative of HIV/AIDS in South Africa, I will present and explore key theoretical 
debates surrounding racial capitalism and neoliberalism in South Africa and its connection to 
public health, disease patterns, and the controversies and conspiracies of the HIV/AIDS 
crisis . I will draw on this later to argue that pharmaceutical companies, through their 2
weaponisation of intellectual property, express a logic of racial capitalism and neoliberalism’s 
accumulation by dispossession that morally obligates them to be ever-expanding. In the 
second section, I explore Mary Douglas’s work on dirt as disorder to complete my 
overarching argument: that the moral world of Big Pharma, with its imperative of maximum 
accumulation and expansion, conceptualises generic medicines as disorder (though it is just 
moderation) and therefore something that must be quashed. 
!
I 
!
Of Conspiracies and Controversies: HIV/AIDS in South Africa 
!
In the foreword to AIDS and South Africa: The Social Expression of a Pandemic, Archbishop 
Desmond Tutu retrospectively describes the bittersweetness of apartheid’s end: another crisis 
was coming (Tutu 2004, xi). In the same essay, Tutu goes on to reiterate that for him, HIV/
AIDS is ‘the new apartheid’. This phrase is our point of entry to the histories of HIV/AIDS in 
!13
 The issues of private healthcare in South Africa are beyond the scope of this dissertation. 2
South Africa. By linking HIV/AIDS and apartheid together, Tutu points to the urgency of 
tackling the crisis and the vital link between the two phenomena. The first part of my 
theoretical framework, as explored below, describe this link and lays the foundation for an 
understanding of HIV/AIDS as discerning. Or in other words, locating HIV/AIDS within a 
South African history of disease that runs through the material conditions of racial capitalism, 
segregation, apartheid, neoliberalism.  
!
Fassin (2007) conceptualises the South African AIDS crisis as a series of controversies: from 
the state’s AIDS denialism; to the development of Virodene (Fassin 2007; Decoteau 2013), a 
drug claimed to cure HIV/AIDS made from the African potato that was later shown to have 
no biomedical effect; to the conspiratorial rumours that Western powers had injected HIV/
AIDS into the African population to ‘cleanse’ the continent; and to the controversies around 
drug pricing of essential branded medications (Fassin 2007). Conspiracy and controversy 
have overlapped in crucial  ways in the history of HIV/AIDS in South Africa and as part of 
their nature carry kernels of truth and legitimate fears rooted in apartheid (Decoteau 2013; 
Fassin 2007; Mbali 2013).  
!
AIDS denialism is at the forefront of the HIV/AIDS crisis in South Africa. A controversial 
belief that ARVs are toxic and HIV does not cause AIDS, held by Thabo Mbeki, South 
Africa’s second president, and a number of significant members of his Department of Health. 
At first blush, AIDS denialism comes off as preposterous and unforgivable, especially 
considering its contribution to the delay in antiretroviral rollout, and the death of almost half 
a million African lives. Yet, as a number of scholars (Decoteau 2013; Fassin 2007; Mbali 
2013) document, AIDS denialism was inspired by the deep belief that the international public 
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approach to AIDS was fundamentally racist and colonial. Mbeki’s argument for AIDS 
denialism was three-pronged: he was critical of the assumptions of African sexuality  that ran 3
as an undercurrent through international epidemiological approaches to the causes of HIV; he 
questioned the pharmaceutical industry’s power and the huge profits it would gain from the 
AIDS epidemic in Africa if antiretrovirals were purchased from them; and lastly, Mbeki 
argued that biomedical science was inherently wrapped in an imperialist paradigm that did 
not take into account the African cultural and racial identity. For Mbeki, indigenous healing 
was the way forward in treating HIV/AIDS in South Africa and the state pitted indigenous 
healing methods against biomedical science (Decoteau 2013, 18). To understand this better, 
we must take a look into the political economy of disease in South Africa.  
!
A Discerning Disease 
!
Apartheid has hewed the patterns of disease, as well its health systems and services 
(Manderson and Levine 2006; Yen 2016; Fassin 2007; Gilbert and Walker 2002). By 
describing HIV/AIDS as ‘a discerning disease’, it is possible to view its pattern not as a 
‘natural path’ but one which runs along constructed tracks. The tracks have origins not just in 
apartheid, but in racial capitalism.  
!
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 Mbeki’s criticism comes from the concern that Western representations of the HIV/AIDS epidemic 3
was fuelled by racist assumptions about the voracity of Africans’ sexual appetites, and their inability 
to practice ‘safe sex’ (Decoteau 2013, 89). Indeed, actual remarks from the heads of pharmaceutical 
corporations express adjacent views. It is easy to see how truth and conspiracy become blurred in the 
post-colony, especially with stakes as high as HIV/AIDS. 
The term ‘racial capitalism’ came to prominence in the 1970s, located within the debate 
between Marxist revisionists and Anglophone liberal scholars. The liberals argued that 
economic capitalist structures should work independently of the state assuming first, state 
neutrality, and second, the feasibility of a barrier between the political and economic spheres. 
There are two important moral logics inherent to the liberal belief. One, that capitalism, 
through minimum state intervention, would create ‘colour-blindness’ in which any and all 
kinds of racial prejudice and discrimination would be eradicated. Instead, a bold new liberal 
world would emerge in which new forms of social interactions and subjectivities would 
become the norm, founded on the so-called rational economic principles and values of 
enlightened self-interest. Two, that capitalism would bring ‘progress’, implying that Western 
rationality would transform any pre-modern backwardness to culminate in the subjectivity of 
a post-racial, autonomous, and bourgeois South African individual (Cloete 2014, 34-35). As 
late as 1991, Bruce Bartlett, ex-domestic policy advisor to Ronald Reagan, argued that “…a 
free economy is a necessary, and perhaps even a sufficient, condition for resolution of the 
racial problem of South Africa” (Bartlett 1991, 64). 
!
 For South African Marxists, however, apartheid was a direct result of capitalism (Cloete 
2014, 36), a perspective that this paper agrees with. The pamphlet Foreign Investment and the 
Reproduction of Racial Capitalism in South Africa was published in 1976, written by white 
South African Marxists Martin Legassick and David Hemson. They argued that modern 
expressions of racism in South Africa have been shaped by and are dependent upon the 
processes of capital accumulation and the state’s responses to it (Hudson 2018). Indeed, the 
term ‘racial capitalism’ was specifically used to critique the above-mentioned South Africa 
liberal who believed that racism and apartheid would ‘self-correct’ through the free-market. 
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Neville Alexander, a prominent activist and academic from outside the ANC pushed the 
argument of racial capitalism forward, fully embracing the term in a 1983 speech in 
Hammanskral. This speech was later published in a collection of Alexander’s speeches, Sow 
the Wind. Alexander argues that the battle against apartheid is only the beginning of the war 
against the interests and structures that were the basis of apartheid: racial capitalism 
(Alexander 1985, 41). Indeed, as Alexander (1985), and Legassick and Hemson (1976) argue, 
capitalist institutions have had an indelible effect on South Africa, influencing its political 
economy and health system to a far greater extent than other post-colonial nations across 
Africa and Asia (Coovadia et al. 2009, 826-828). To contextualise racial capitalism and link it 
to public health and disease, we now turn to the history of industry in South Africa.  
!
Diamonds were discovered in Kimberley in 1867 and gold in the Witwatersrand in 1886. This 
had a profound effect on South African society and galvanised the transformation of South 
Africa from an agricultural economy to an industrial one. Mining became the cornerstone of 
the economy and in order to sustain the industry the demand for cheap black male labour 
skyrocketed. With huge foreign investment being pumped into South Africa, it became 
necessary to procure this labour through any means necessary. Through taxes, coercive 
legislation, punitive control of desertions, and restrictions to access to land and the means of 
production, black male labourers were forced to migrate to the towns and the mining areas. 
This system was not only instrumental in breaking the backbone of the rural black 
agricultural economy, but it became the linchpin of subsequent economic, political and social 
developments. From 1948, with the Nationalist Party in power, the system of apartheid was 
put in place. This system was based on racial classification from birth. South African people 
were divided into four racial categories: European (white), Asian (Indian), coloured, or Bantu 
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(black). This was an unyielding racial hierarchy with whites at the peak, and it determined 
every factor in a person’s life. The racial hierarchy decided where a person could live, go to 
school, work, whom they could marry, their right to vote, and the amount of resources 
granted to their education, healthcare and pension. All laws were reinforced with stringent 
state control and repression. Black peoples were forced onto specially designated rural labour 
reserves called bantustans. They were forced to carry passes that showed their right to work 
and live in urban areas, a practice that was policed brutally. With a huge lack of employment, 
physically-able black men had no choice but to leave home in the bantustans and look for 
work in urban areas, a pattern of forced migration that harks back to the beginning of large-
scale industry in South Africa. 
!
The 1995 National Household Survey of Health Inequalities in South Africa revealed the 
race-based difference in access to public healthcare. In the previous year, the year in which 
apartheid ended, 37 percent of Africans and 30 percent of Coloureds had not received 
healthcare in comparison to Whites at 17 percent and Indians at 18 percent (Gilbert and 
Walker 2002, 653) As such, disease patterns in South Africa have historically been majorly 
determined by the socio-political processes. The spread of tuberculosis is an important 
example. Apartheid’s agricultural policies supporting large-scale agriculture were 
instrumental in pushing millions of African peoples into reserves, homelands, and townships 
(Coovadia et al. 2009, 819). This urbanisation was rapid and uncontrolled, causing high 
levels of urban and rural poverty, and the spread of diseases linked to population mobility and 
impoverishment, amongst others issues (Gilbert and Walker 2002, 653). Due to racial 
segregation and no proper housing for the migrant population, urban African areas featured 
overcrowded, unsanitary hostels and slums. Tuberculosis spread dangerously quickly in the 
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reserves due to high numbers of mine workers returning to their families, and the forced 
return of workers too ill to be productive. In parts of the rural reserves of Ciskei and Transkei, 
more than 90 percent of adults were infected with tuberculosis (Coovadia et al. 2009, 819).  
!
Similarly, HIV/AIDS has shown itself to be a discerning disease. In other words, the more 
marginalised the population, the higher the infection rate (Decoteau 213, 6). Statistics show 
that women have a higher prevalence rate, regardless of age, and the South African black 
population has a higher HIV prevalence than any other racial group. Lower socio-economic 
class, rural, and informal settlement populations similarly have higher prevalence rates. The 
link between current vulnerable groups and apartheid is striking. Vulnerability, thus, also 
reveals itself to be the affective dimension of the material conditions created by racial 
capitalism. 
!
Original Sin  
!
A vital aspect of racial capitalism is Marx’s critique of ‘the so-called primitive accumulation’. 
This argues that no amount or method of accumulation by itself produces capital and 
capitalism. The origins of capitalism occurred through a process of transformation in social 
property relations that precipitates capitalist ‘laws of motion’: “the imperatives of 
competition and profit-maximization, a compulsion to reinvest surpluses, and a systematic 
and relentless need to improve labour-productivity and develop the forces of 
production” (Wood 2002, 36, italics in original). The ‘laws of motion’ create the necessity for 
ever-expansion, as well as the methodologies through which this expansion can take place. 
Marx locates the actual process (rather than the “so-called”) of primitive accumulation to the 
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English countryside and the emergence of new agrarian relations in which landlords 
increasingly took rent from the commercial profits of capitalist occupants, while 
simultaneously many small producers were dispossessed and became wage labourers (Wood 
2002, 36, 48). This rings particularly true in South Africa’s case, where the rise of capitalism, 
inseparable from the rise of segregation and apartheid, created generations of black urban 
proletariat (Drew 1991; Alexander 1985; Maharajh 2011) forced migration, dispossession, 
and a privatisation of the commons as well as the preconditions necessary for the spread of 
diseases like tuberculosis.  
!
Let us now take a closer look at these preconditions and their underlying moral justification. 
Wood (2002) questions why only British colonialism had the specific effect it did, that of 
converting wealth into industrial capitalism in ways that other colonists (such as the Spanish) 
did not have at home and across the globe. Legassick and Hemson (1976) too point out that 
segregation in South Africa was not invented by Afrikaners. Instead the British state, acting 
for the interests of British capital tied up in the South African economy, intervened in 1900 to 
take on a hegemony which laid the foundations of South Africa’s racial capitalism and the 
apartheid regime. Legassick and Hemson argue that segregation’s (and naturally, apartheid’s) 
assumptions, ideological elaboration, and policy implications were generated between 1900 
and 1910 under the British Imperial administration in South Africa, and were done so by 
those that self-identified as humanitarians (Legassick and Hemson 1976, 3). Wood argues 
that in order for British colonialism and resulting industrial capitalism to take the form that is 
has, “much, if not everything, depended on the social property relations at home in the 
imperial power, the particular conditions of systemic reproduction associated with those 
property relations, and the particular economic process set in motion by them” (Wood 2002, 
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149). Property, then, and the moral justification for accumulation of property can be seen to 
lie at the heart of the imperialism present in the British Empire and can be connected to the 
racial capitalism of South Africa.  
!
Ince (2018) argues that Locke’s theory of private property and famous pronouncement on 
America heavily influenced the imperial turn in political theory. Part of Ince’s argument is 
that Locke’s theory of private property expressed a particular capitalistic worldview based on 
“the productive capacities of labor for transforming inert nature into an ever-expanding 
domain of value” (Ince 2018, 39). Though the argument and analysis is located in English 
imperial ambitions in America, as is the quote above, Ince’s work gives us important insight 
into the morality of accumulation. In the Second Treatise, Ince shows us, Locke begins with 
the theological idea that God’s command is for the earth to be used for the benefit of 
mankind, and arrives at the necessity for accumulation that constructs seventeenth-century 
colonial capitalist action as legitimate and morally lauded (Ince 2018, 48). Though there is 
not enough space here to fully pick apart Locke’s theory of private property, a concept that is 
used to prop up the moral necessity of accumulation is ‘waste’.  
!
A closer look shows Locke to be deeply disturbed by the idea of the waste of earthly material. 
For him, enclosing and improving the material is efficient and fulfilling of God’s purpose 
(Ince 2018, 49). Thus, though Locke did not consider Native Americans to be ‘irrational’ or 
‘stupid’, and was aware of their complex systems of barter and gift, he also clearly believed 
that their use of the ‘commons’ was a waste. Rather, for Locke, Native Americans would 
benefit in material terms if their territories were enclosed and improved by English colonists, 
or in other words that even if there was a loss, they would be more than compensated (Ince 
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2018, 50-56). For Locke, the moral necessity of accumulation also meant that there needed to 
be a way to store the build-up without it returning to the waste of the commons. Money, and 
the  imperative of money’s expansion, returns as a function in the same way that the 
enclosing of land does: for the achievement of divine purpose (Ince 2018, 52-3). In this 
understanding, the accumulation of property, with money as its natural extension, is nothing 
short of following God’s command. Thus, it can be seen how the African peoples of South 
Africa, sitting on (and so wasting) the gold and diamond mines of the country, must be 
dispossessed and placed in submission for the purposes of God’s will. In reference to Wolfe’s 
quote above, the native South Africans provided both the land and the labour, the latter of 
which was demanded in ferocious amounts resulting in the production of racial capitalism 
that is both local to South Africa, and also located within a global history of morally justified 
colonialism. Indeed, the link of the moral logics of accumulation and expansion to racial 
capitalism and the rise of segregation become clear as a particularly English kind of 
colonialism. Connecting accumulation to later British imperialism and colonialism and the 
more contemporaneous imperialism of the U.S.A, Harvey writes,  
!
The American bourgeoisie has, in short, rediscovered what the British 
bourgeoisie discovered in the last three decades of the nineteenth century, 
that, as Arendt has it, ‘the original sin of simple robbery’ which made 
possible the original accumulation of capital ‘had eventually to be repeated 
lest the motor of accumulation suddenly die down’. 
Harvey 2003, 182 
!
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This repetition, Harvey argues, occurs through a process he calls ‘accumulation-by-
dispossession’. Describing the current moment of U.S. imperialism and the proliferation of 
neoliberalism across the world, ‘accumulation-by-dispossession’ is the new form of 
‘primitive accumulation’.  
!
An Eerie Coincidence 
!
Neoliberalism is not easily defined. As a doctrine of political economy, its origins date back 
to the late 1930s, taking birth in a largely isolate and ignored collection of thinkers such a 
Milton Friedman. It was Margaret Thatcher and Ronald Reagan, who in the 1970s, turned to 
neoliberalism for answers to the economics difficulties of their time. By moving away from 
the welfare state towards conscious support for the ‘supply-side’ conditions of capital 
accumulation, Thatcher and Reagan triggered an almost overnight policy framework change 
for the World Bank and the IMF. The emphasis was placed on the the privatisation and 
liberalisation of the market, effectively creating a new set of commons to be enclosed by state 
policies (Harvey 2003, 158). Through this, entirely new processes of accumulation-by-
dispossession have emerged. A primary vehicle for accumulation-by-dispossession has 
revealed itself to be the forcing open of markets throughout the world by imperialistic and 
institutional pressures from the IMF and the WTO. These pressures are in turn given power 
through the backing of the U.S., and to a lesser degree Europe, for the purpose of sanctioning 
countries who remain even vaguely protectionist (Harvey 2003, 181). The expansion of the 
intellectual property rights regime in the WTO negotiations, leading to the TRIPS agreement, 
and the weaponisation of the regime by the pharmaceutical industry are a striking example of 
accumulation-by-dispossession and demonstrative of the new levels of abstraction to which 
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the moral justification of private property have been taken. This will be discussed in further 
detail in the chapter three. As I have shown in previous sections, the material conditions of 
epidemics are vital to understanding their spread and systems of power in a society. 
!
In an eerie coincidence of global proportions, AIDS and neoliberalism 
share a common chronology and impact. AIDS and the industry that has 
grown up to manage, control, and capitalize on the disease is deeply 
implicated in neoliberalization efforts at multiple scales, even more so as 
biopolitical concerns are increasingly a focus of government at the 
international, national, and civil society levels.  
Decoteau 2013, 136 
!
In South Africa’s case, foreign investment and interference (as Legassick and Hemson 1976, 
and Alexander 1985 have so eloquently argued) have always had a major role to play in the 
political economy of the country  and disease. As Tutu called HIV/AIDS ‘the new apartheid’, 4
he called the international political-economic system ‘global apartheid’ (Bond 2001, xi). A 
striking example is the World Bank’s treatment of access to water. Through the privatisation 
of water, in which consumers paid for the water they used rather than receiving it as a free 
and natural resource, South Africans were increasingly excluded from accessing water. With 
less revenue for the companies and subsequently higher prices, water steadily became less 
!24
 The apartheid state had already adopted the doctrine of neoliberalism and begun its implementation 4
long before the ANC came to power in 1994. This meant that structural adjustment programmes, 
unlike in the rest of Africa and the Third World, were unnecessary, thus giving South Africa a history 
of neoliberalism that differs greatly from others (Decoteau 2013, 9). 
affordable to low-income South Africans. One devastating outcome was the necessity of 
turning to other water supplies, triggering a cholera epidemic (Harvey 2003; Bond 2001). 
!
II 
!
Matter out of Place 
!
In Agenda for an Anthropology of Pharmaceutical Practice, Mark Nichter and Nancy 
Vuckovic call for a broadening of the scope of research for a number of pharmaceutical 
issues. The first one they address is the idea of “medications as vehicles of ideology”. For 
Nichter and Vuckovic, medications “link the physical body to the social body and the body 
politic” (Nichter and Vuckovic 1994, 1509-10). By taking seriously this link, the case for a 
morality of branded and generic ARVs becomes more clear. As branded medicines then bring 
with them the moral world of Big Pharma, what do generics represent? Mary Douglas helps 
us here with the seminal text Purity and Danger (1966). Douglas writes,  
!
…the old definition of dirt as matter out of place [is] a very suggestive 
approach. It implies two conditions: a set of ordered relations and a 
contravention of that order. Dirt, then, is never a unique, isolated event. 
Where there is dirt there is system. Dirt is the by-product of a systematic 
ordering and classification of matter, in so far as ordering involves 
rejecting inappropriate elements…it is a relative idea. Shoes are not dirty in 
themselves, but it is dirty to place them on the dining-table…In short, our 
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pollution behaviour is the reaction which condemns an object or idea likely 
to confuse or contradict cherished classifications.  
Douglas 1966, 34-6 
!
A study in symbology, Douglas (1966) brings understandings from so-called ‘primitive’ 
cultures into the ‘enlightened’ West, arguing that there really is no difference: there are only 
systems and that which threatens the system. In the case of Big Pharma, I have laid down the 
theoretical framework  for the argument that their moral logic of accumulation is is embedded 
into branded ARVs. With Douglas’s understanding of disorder as dirty and dirt as ‘matter out 
of place’ (i.e. out of place in a particular system), we are able to theorise generic ARVs. In the 
moral world of Big Pharma, that which does not go to an extreme of accumulation and 
expansion is the enemy. Framed in this way, it becomes more understandable why generics 
are so threatening to Big Pharma. Perhaps it is not simply that their monopoly is challenged, 
but also because of the moderation that comes from cheaper, more accessible medications.  
!
Before we can explore the scope of Douglas’s work, three primary criticisms must be 
acknowledged: first, that by assuming a direct causality between society’s structure and its 
classifications of purity and impurity, a homogenising effect takes place; second, 
sociobiological workings of the disgust sensation are not accounted for; and third, definitions 
of purity and impurity have been drawn from Christian traditions despite being universalised 
by Douglas (Duschinsky 2016, 6). Within the context of an attempt to theorise mechanisms 
of disgust and hygiene, Douglas falls short, particularly because her starting point are non-
Western ontologies such as the Hindus (Douglass 1966). In later years Douglas admitted, “the 
only universalistic about purity is the tendency to use it as a weapon or tool” (Douglas 1997 
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as quoted in Duschinsky 2016). Indeed, this is what makes Douglas’s work so applicable to 
branded and generic ARVs in Big Pharma’s moral world. In the fifty-three years since Purity 
and Danger’s publication, the scope of the work has expanded far beyond symbolic and 
religious anthropology. Douglas’s ideas have been applied to puns in the English class system 
(Herzfeld 2016); the psychology of fainting and vomiting (Gilchrist and Ditto 2016); and 
Shakespeare’s works (Firestone and Lyne 2016) to name only a few. Particularly relevant is 
Williams’ (2016) work on political activists as ‘dirty’. It provides a vital insight into how 
images of pollution mark those against the established order (Williams 2016, 70). This is 
especially interesting in the discussion of generics producers as ‘pirates’. By using Douglas’s 
work, understanding the systematic offensive against generics becomes clearer. Generics are 
not oppositional in the sense that they are anti-capitalist. Generics producers are still of 
capital, yet within the context of Big Pharma’s moral world, they are moderate capital and 
thus ‘wasteful’ (in Locke’s definition).  
!
!
!
!
!
!
!
!
!
!
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Discussion and Analysis 
!
This chapter is an attempt at moral world building. Here I will argue that, for Big Pharma, 
accumulation by dispossession is nothing less than a moral imperative. Branded medicines, 
then, especially in the context of HIV/AIDS, come through and with a morality of 
accumulation and expansion at all costs (of lives) and refer us back to “the bloodstained body 
of the drug” (Martin 2006, 284). In this chapter I intend to lay out how intellectual property, 
specifically patents, and their institutionalisation as a regime has been used as a vehicle for 
Big Pharma’s morality through the metaphor of ‘piracy’. I draw largely from Drahos and 
Braithwaite’s (2002) excellent work Information Feudalism: Who Owns the Knowledge 
Economy? to draw attention to particular histories, fears, and policies that point to a moral 
logic of accumulation. 
!
Piracy as Pretext  
!
The moral fear around ‘wasting’ material resources if land does not become private property, 
as theorised by Locke, has been replaced in the debate of branded versus generic medicine 
with the metaphor of ‘piracy’. For Big Pharma, intellectual property protects them as 
‘inventors’ and their narrative of the history of IP is something like a fairy tale: “The patent 
was a contract between the state and the inventor in which the inventor disclosed their 
invention to the world in return for a limited period of monopoly. Once the knowledge was 
made public, everybody could make the invention to which the knowledge related. In this 
way the story has a happy ending. The inventor benefited and so did society.” (Drahos and 
Braithwaite 2002, 42). Of course, what the historical record actually shows about patents is 
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that it has always been accompanied by “a ruthless trade morality” (Drahos and Braithwaite 
2002, 35), or a logic of accumulation.  
!
In February of 1998, represented by the South African Pharmaceutical Manufacturer’s 
Association (PMA), thirty-nine Big Pharma companies sued the South African government in 
the High Court of Pretoria. This came a year after the introduction of the Medicines and 
Related Substances Control Amendment Act (Medicines Act): an Act that had provisions for 
the import of generic HIV/AIDS medicines to treat an increasingly devastating HIV/AIDS 
epidemic in South Africa. For Big Pharma, this provision was a blatant violation of the World 
Trade Organisation’s (WTO) patent protections. Backed by the U.S. government, South 
Africa was threatened with trade sanctions and the removal of aid if they did not revoke the 
Act’s generics provisions (Owen 2013, 262). For the country only just emerging from the 
apartheid era, the Medicines Act was important to the reworking of a deeply unequal and 
racially segregated public health system. The import of generics would help achieve lower 
drug costs and greater access to essential medicines. This trial became the global symbol for 
defence of “the public health exception”. The exception allowed for specific procedures in 
the international legislation that governed intellectual property in the instance of a “national 
emergency or other circumstances of extreme urgency,” including a “public health 
crisis” (Fassin 2007, 67). 
!
For Big Pharma, the provision for importing generics was nothing short of theft or ‘piracy’. 
Indeed, since the 1980s, the discursive construction of generics producers as ‘pirates’ and 
‘thieves’ (Owen 2013; Drahos and Braithwaite 2002) was an important aspect of their 
lobbying for the globalisation of the intellectual property rights framework through the 
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medium of TRIPS. Intellectual property rights, argue Drahos and Braithwaite (2002) have 
been used as tools of censorship and monopoly from the very beginning. Copyright first 
appears in 1557 in England as a kind of printing privilege granted by Queen Mary to the 
Stationers, a craft guild. Over time, the Stationers became an extension of the state, with the 
powers of search and seizure. The Stationers spend a lot of time destroying printing presses 
and jailing those whose printers are not part of their guild, as well as fighting a perceived 
‘piracy’ that they have created themselves through a brutal monopoly (Drahos and 
Braithwaite 2002, 29-30). 
!
Drahos and Braithwaite (2002) connect the metaphor of piracy used by Big Pharma to the 
real acts of piracy that helped Queen Elizabeth I’s England to flourish and the North 
American colonies to grow. Famous pirates made their name during this time such as Captain 
John Avery and William Kidd, part of which meant the slaughter of those on the coasts of the 
Red Sea, Persian Gulf, or the Coast of Malabar. Indeed, it was “universal pirate opinion that 
it was no sin for Christians to rob heathens” (Drahos and Braithwaite 2002). Later, the 
rhetoric of piracy was used throughout British colonial rule in diverse ways: from using the 
so-called ‘piracy’ of Malays and others in Southeast Asia as ground for military interference, 
to a drawn out and brutal offensive against Anglo-American pirates who threatened the 
shipping lanes necessary to Britain’s hegemony. “Corpses dangled in chains in British ports 
around the world ‘as a Spectacle for the Warning of others’” (Drahos and Braithwaite 2002, 
24) and indeed the practice of ‘as a Spectacle for the Warning of others’ has continued in 
much more abstract ways, such as trade sanctions, warning lists, and political bullying. The 
rhetoric of piracy in the intellectual property rights regime that surrounds biomedicine and 
technology has a popular association with a history of savagery, desperation, and illegality, 
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and a lesser known association with the weaponised metaphors of economic and political 
gain. Or in other words, expansion and accumulation. It is fascinating to see the reuse of 
metaphors from the time of primitive accumulation (the seventeenth century) in the time of 
accumulation of dispossession. As ‘piracy’ lends Big Pharma a powerful metaphor of good 
(Big Pharma) versus evil (generics producers) (Owen 2013; Drahos and Braithwaite 2002), 
an acute sense of morality begins to take shape. 
!
One of my informants (Informant A) works as a campaigner against the patent laws choking 
people’s access to medicine in South Africa. They told me,  
!
I don’t think that people are actually aware of the greed that 
pharmaceuticals have. I think it also goes back to the political 
understanding of everything that’s at play. I think that generally there isn’t 
actually awareness of how they’re playing the system and how they’re 
actually using the system to sort of, to make more profit, to really put 
people’s lives on the line. I think we just look at them as these inventors and 
yes, they do great work by inventing, like, all these drugs, all this life-saving 
medicine and stuff, but I also think they wield their power, obviously their 
financial power that they can actually contribute to and influence key 
decisions in government…it’s not in the public eye, you know, that there is 
medicine that can actually save you, to save you from dying but some 
pharmaceutical decides that they won’t make it available in some specific 
country and then you can’t access it. People think, “Oh well, there’s no 
cure, there’s nothing that can actually save me.” 
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They conceptualise Big Pharma as tricksters, saying “Pharmaceuticals still get new tricks to 
trick the system”. In general, when a pharmaceutical corporation develops a medicine, it 
places patents not just on the medicine itself but on every compound in the medicine, the 
dosage methods, the processes of producing it. Some information is also held back and 
protected under trade-secret law. Brand name identity is thus preserved under trade mark law 
and the written information surrounding the compound is protected by copyright, ensuring 
that this wall of intellectual property lasts longer than the length of any single patent (Drahos 
and Braithwaite 2002, 6). Manipulation of this system happens constantly to ensure generics 
producers are excluded from the market. Informant A tells me about a tactic that is used by 
Big Pharma to keep generics out of market for as long as possible called ‘Evergreening’: 
“where pharmaceutical companies will develop a drug that would be given a twenty-year 
patent and in that process, maybe fifteen years down the line of the patent, they’ll tweak, or 
rather just change a small molecule within the drug, or package it in a different way and they 
will apply for another patent to extend their monopoly for another plus years.”. The ‘piracy’ 
of generics medicines producers could arguably then be of any compound, process, or dosage 
method of any medicine, rendering Big Pharma as the ultimate monopoly over medicines 
(Boldrin and Levine 2008). By framing generics as ‘pirates’ and their own ever-expansion as 
‘protection from theft’, Big Pharma presents its use of the intellectual property rights system 
as morally necessary.  
!
Behaviours of Accumulation and Extraction 
!
Primitive accumulation’s seizing of land for property has become more abstract during 
accumulation as dispossession. Here, the accumulation of intellectual property is simply one 
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aspect of a larger project of neoliberalisation. In this section I will outline the behaviours of 
accumulation and expansion that are evident in the globalisation of the intellectual property 
regime. I have already argued that these behaviours are self-justified as working against 
‘piracy’. The rhetoric of ‘piracy’ makes expansion a moral imperative and the processes of 
making this imperative come to life connect back to racial capitalism. This will be explored 
in the following section.  
!
TRIPS as an agreement is about more than patents: it sets minimum standards in copyright, 
trade marks, geographical indications, industrial designs, and lay-out designs of integrated 
circuits. It was the first stage in ensuring that the morality of expansion reproduces globally 
as the intellectual property standards in TRIPS obligate all members of the WTO (Drahos and 
Braithwaite 2002, 10). For Big Pharma, TRIPS will ensure the enclosure of biotechnology 
through patents and trade secret law. It also functions as an important vehicle for 
accumulation by dispossession through the forcing open of world markets, exactly like India: 
a country labelled as a notorious ‘pirate’ for making generics a fundamental part of their 
national pharmaceutical industry. Indeed, as a combination of a market-opener and a 
globalisation of the morality of accumulation, TRIPS can be seen as a cog in the engine 
wheels of “the motor of accumulation” (Harvey 2003, 182). 
!
TRIPS has been effective since 1995 and was negotiated during the Uruguay Round of the 
General Agreement on Tariffs and Trade (GATT). Those missing from the important 
negotiation meetings and tables are easily identifiable: African, Asian, South American 
countries were repeatedly denied entry into spheres in which they might have the power to 
object and derail TRIPS. Alongside this came a system of coercion and blindsiding in which 
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Third World countries were threatened through trade sanctions, and were also unprepared for 
the level of capital that had been sunk into intellectual property lawyers and infrastructure. 
India was the last stand against TRIPS. When finally having to sign during the Final Act of 
Marrakesh in April 1994, a number of Indian parliamentarians and members of the judiciary 
delivered rousing speeches about the recolonisation of India (Drahos and Braithwaite 2002, 
146). However, the Indian pharmaceutical industry, along with every other member of the 
WTO was now forced to play by intellectual property rules set in Washington and New York 
(Drahos and Braithwaite 2002). In the aptly named TRIPS Was Never Enough, Sell says, 
“Despite the fact that a TRIPS advocate triumphantly exclaimed, “we got 95% of what we 
wanted,” that 5% has always mattered, and 95% was never enough. While many countries 
believed that they were negotiating a ceiling on intellectual property rules, they quickly 
discovered they actually had negotiated only a floor.” (Sell 2011, 448). After TRIPS came 
TRIPS-plus, U.S.-plus, and ACTA-plus, making TRIPS look like a walk in the park in 
comparison to the stringency that these initiatives have brought (Sell 2011, 448). TRIPS-plus 
in particular targets the import of generic medicines and the logics of expansion and 
accumulation present themselves again.  
!
A crucial aspect of primitive accumulation, accumulation by dispossession, and racial 
capitalism is extraction. Within the context of pharmaceutical intellectual property practice 
and TRIPS, three important kinds of extraction take place: the forcing open of markets 
through the obligation of building intellectual property infrastructure (Drahos and 
Braithwaite 2002); the theft from the collective knowledge of indigenous peoples 
(Olufunmilayo 2006; Drahos and Braithwaite 2002); and the outsourcing of clinical trials to 
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the Third World while producing drugs for a Western market (Drahos and Braithwaite 2002; 
Fassin 2007; Lurie and Wolfe 1997; Angell 1997). 
!
Minds and Bodies for Extraction 
!
In the world of intellectual property, those who hold the webs of patents, patent lawyers, and 
the capital to keep it all spinning, are lords of the knowledge economy and thus, knowledge 
exporters. Those who are knowledge poor, like South Africa and other Third World countries, 
are also knowledge importers (Drahos and Braithwaite 2002). TRIPS ensures that not only 
will knowledge poor countries have to standardise themselves to Western intellectual 
property rights, but they will have to pay dearly for the privilege. The message of the 
discourse around piracy has been that governments of other countries are stealing from the 
minds of U.S. inventors by not following patent protection. This narrative is connected with 
larger processes of the world order. In the 1950s, pharmaceutical corporations, particularly 
Pfizer International, made sweeping overseas sales figures. Due to recently independent post-
colonial nations trying to rebuild themselves politically and economically, national 
pharmaceutical industries were nascent or non-existent. Drugs had to be imported and Pfizer 
profited. Countries like India and China were at first long-term prospects of profit. As their 
national pharmaceutical industries grew, they quickly became dangers to an established 
global system of branded medicine, one rooted in colonialism and imperialism (Drahos and 
Braithwaite 2002). The avid extension and proliferation of the intellectual property regime, 
particularly in regards to pharmaceuticals, can thus be seen as a legal disciplinary mechanism 
for those countries daring to circumvent Big Pharma. By pouring resources into an 
infrastructure to support intellectual property rights, (Drahos and Braithwaite 2002) lower 
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income countries (primarily post-colonies) are being pulled away from investing in basic 
human rights needs, such as access to medicines. Here we see Harvey’s accumulation by 
dispossession clearly.  
!
Though Harvey is less particular about the racial aspect of the extraction, Alexander, 
Legassick and Hemson, Tutu, and even Mbeki make very clear that there is a power 
imbalance between extractors and those extracted from. Drahos and Braithwaite (2002) point 
to the ways in which racist narratives of the ‘East’ were mobilised for the movement of the 
U.S. government to put in place sanctions against Asian countries who did not yet follow 
patent protection laws in the 1980s and 1990s, forcing them to behave. Indeed, this example 
of a racial and imperial attitude seems to form a stubborn undercurrent not just through 
TRIPS but through Big Pharma’s more specific practices in the Third World. For example, 
Western intellectual property rights did not recognise the rights of indigenous peoples. By the 
time evidence proved individual pharmaceutical corporations were stealing indigenous 
peoples’ collective knowledge, TRIPS had been set into stone (Drahos and Braithwaite 2002, 
71). Unethical clinical trials are another striking example. Lurie and Wolfe (1997) describe 
the deaths of hundreds of infants in the Third World who were needlessly unethically infected 
in trials of interventions to reduce perinatal transmission of HIV. Even trials that are ‘ethical’, 
however, are often conducted within vulnerable populations in Third World countries, 
creating a cheap clinical trial pool for pharmaceutical corporations to test drugs on (Fassin 
2007; Lurie and Wolfe 1997; Angell 1997). Informant C, a doctor, tells me they feel that there 
have been so many conspiracy theories about the HIV/AIDS crisis in South Africa that they 
feel almost reluctant saying what they think out loud. Yet when I ask about their opinion of 
Big Pharma’s role in Africa, they tell me with a sigh: 
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South Africa and Africa is like, what’s the word? a testing ground. I hate 
saying that but I sometimes do feel. I hate saying that because it’s putting the 
conspiracy theories, the cynicism into something. I guess, that it’s my feeling: 
it’s subjective rather than objective. When I say conspiracy theory, I mean it’s 
something that you don’t want to believe is happening but you know that there 
is probably truth in it. 
!
Their hesitation comes with high stakes: the only reason their partner is able to get treatment 
for skin cancer is due to access to a clinical trial. Otherwise, the treatment costs R95, 000 
every three weeks for two years. “They are doing some good work out there,” they tell me. 
Big Pharma’s moral location in South Africa is nebulous and uneven, as is the ‘global 
apartheid’ of neoliberalism. Indeed, their practices follow the same logic of racial capitalism: 
the bodies of colonial subjects that propped up the Empire have become the bodies of post-
colonial subjects who prop up a much more diffuse, abstract corporate Empire. The lines 
between conspiracy and controversy are just as thin across the world as they are in South 
Africa.  
!
When it came to HIV/AIDS, then, is it any wonder that Mbeki’s AIDS denialism was so 
ardent? In the story of HIV/AIDS in South Africa, and its larger history of medicine, the lines 
between controversy, conspiracy, and colonialism are incredibly thin. After the end of 
apartheid, reports detailed a litany of health violations by the apartheid government. 
Beginning with the systematic underfunding of health care in bantustans, the list of crimes 
described is deplorable: the avoidance of punishment for doctors who covered up torture; 
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refusing emergency medical care to doctors, or breaking patient confidentiality to report to 
the security forces; non-consensually injecting women with controversial contraceptive 
Depo-Provera; and the actions of Dr. Wouter Basson or “Dr. Death”. Basson was a key 
member of the chemical and biological warfare program of the apartheid government, and 
though never convicted, he was accused of poisoning anti-apartheid activists, producing 
cholera and anthrax, and injecting salmonella and botulism into chocolates (Decoteau 2013, 
88-9). Some claimed that Mbeki had said that the CIA were behind the spread of HIV/AIDS, 
since it served the pharmaceutical companies. Journalists ridiculed Mbeki but it was later 
revealed that there was a very real link between the CIA and the South African military 
intelligence under apartheid and during the international embargo (Fassin 2007, 295).  
!
A doctor (Informant B) who worked through the height of the HIV/AIDS crisis told me in 
reference to HIV/AIDS medicine, “As long as Big Pharma is making money off HIV/AIDS, 
there’s no reason to find a cure.” Describing the helplessness of watching people die every 
day due to no treatment, they tell me that they are glad there are generic ARVs available and 
that the government has made HIV/AIDS treatment so accessible. However, they remain 
unconvinced about the efficacy of some generics, feeling that branded ARVs are proven to 
work. In fact, they are suspicious of the corporatisation of generic medicines within the 
health insurance system of MedicalAid in South Africa. Deals have been struck between 
MedicalAid and generics companies so only particular generic ARVs can be given to patients. 
Yet Big Pharma also produces generics, and the doctor tells me of their wariness of ‘stock-
outs’: when generic ARVs run out in clinics and doctors are forced to prescribe branded 
ARVs. “It’s very convenient,” they say to me. 
!
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Piracy and Disorder 
!
Informant C tells me that they cannot reconcile the worth of lives and Big Pharma’s drive for 
profit. “I just think, it’s all lives,” they tell me with emphasis. Informant D, a nurse in an HIV 
clinic treating sex workers, says the same to me. Indeed, this too was my question at the start 
of my research. Douglas’s work gives insight into understanding the systematic policy-
building around generics. “The only universalistic about purity is the tendency to use it as a 
weapon or tool” (Douglas 1997 as quoted in Duschinsky 2016), ring true with the 
weaponisation of ‘piracy’ as shown in earlier sections. The ‘pirate’ becomes a stand in for 
generics, and so a symbol of theft and disorder that interferes with the ‘natural’ order of 
capitalist accumulation and expansion, one that is inherently racialised. India, for example, 
was labeled as a ‘pirate’. In fact, in the 1960s India had both one of the poorest populations 
and the highest drug prices in the world. Big Pharma were aiming their prices at the small but 
burgeoning class of Indians who could afford Western prices. Thus, developing affordable 
drugs through a national pharmaceutical industry became a priority for India (Drahos and 
Braithwaite 2002, 66). By actually building an industry around medicines of ‘moderation’, 
India remains an important enemy for Big Pharma. The South African case of the PMA v. 
Pretoria that I referred to earlier, was instrumental in beginning a change in rhetoric around 
generics producers from ‘pirates’ to ‘heroes’ with Pretoria’s win (Owen 2013). However, this 
is only in the public sphere. In the corporate sphere (that leaks into the public), managing and 
suppressing the production of generics is a central aspect of TRIPS-plus and U.S.-plus. In a 
moral world that advocates for maximum accumulation, generics as symbolically ‘moderate’ 
forms of accumulation are “matter out of place” (Douglas 1966, 40). Thus, it becomes easier 
to understand the relationship between the drive for profit through branded medicines, and 
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greater access to essential medicines through generics. Within the HIV/AIDS crisis in South 
Africa, then, branded and generic ARVs fit into a deep history of inequality centred around 
racial capitalism, segregation, and apartheid. Generic ARVs thus become matter out of place 
and representative of disorder in a context where the racial capitalist order has seeped into 
every sector of society. 
!
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Conclusion 
!
There is so much more to say. The holes in this work are glaring and can only be resolved 
with long-term ethnographic fieldwork. Histories and moralities of exploitation and 
resistance are jagged, complex, and not generalisable. A weakness in this work has been the 
necessity to generalise at times due to short-term fieldwork and limited scope, as well as not 
having the space to explore methods of resistance. In the process of writing, I have found it 
necessary to remind myself that intellectual property, neoliberalism, racial capitalism, and 
imperialism are not leviathan. There are important ways of resisting, such as the 
judicalisation of healthcare, and grassroots activism that I have unfortunately not been able to 
delve into as a way of rounding out my argument.  
!
Despite this, I hope to have convinced the reader that Big Pharma’s corporate action and 
expansion is also moral action and expansion. Branded drugs so become moral bodies of 
accumulation and expansion. Generics, not in opposition, but in disorder, become bodies of 
moderation. I began this essay by asking ‘why do we not yet have access to medicines?’ and 
an answer slowly begins to emerge: capital and its inequalities reproduce themselves like 
Hydras. In South Africa, the presence of capitalist moderation through publicly available 
generic ARVs is remarkable if uneven. Neville Alexander may not necessarily be proud yet, 
but it is a start. 
!
!
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Appendix 
!
A. Image of interview notes from Informant B as example. All interviews were between fifty 
minutes and one and a half hours. All interviews were recorded except for Informant B’s 
due to a failure with the recording device.  
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